Coya Therapeutics
COYA
26 hedge funds and large institutions have $25.5M invested in Coya Therapeutics in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 1 closing their positions.
700% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 1
200% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 4
37% more funds holding
Funds holding: 19 → 26 (+7)
19% more capital invested
Capital invested by funds: $21.4M → $25.5M (+$4.08M)
4.82% more ownership
Funds ownership: 21.78% → 26.6% (+4.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$3.76M |
| 2 |
DCM
DME Capital Management
New York
|
+$2.54M |
| 3 |
NFSG
Newbridge Financial Services Group
Boca Raton,
Florida
|
+$477K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$293K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$209K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$111K |
| 2 |
Jones Financial Companies
Des Peres,
Missouri
|
-$37.1K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$33.7K |
| 4 |
MCP
Mirador Capital Partners
Pleasanton,
California
|
-$3.09K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.7K |
COYA Hedge Fund Activity: Q4 2024 in Review
26 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Coya Therapeutics (COYA) for Q4 2024, worth a combined $25.5M — up 19% from $21.4M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new COYA positions and 1 closed out — a net gain of 7 holders — while 12 added to existing stakes and 4 trimmed.
The largest buyer was AIGH Capital Management, adding an estimated $3.76M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $111K sold.
- 26 institutional investors held Coya Therapeutics (COYA) as of Q4 2024, up from 19 in Q3 2024.
- Funds reported $25.5M of Coya Therapeutics stock for Q4 2024, up 19% quarter-over-quarter.
- 8 funds opened new Coya Therapeutics positions in Q4 2024 and 1 closed out, a net change of +7 holders.
- The largest Coya Therapeutics buyer in Q4 2024 was AIGH Capital Management, an estimated $3.76M added.
- The largest Coya Therapeutics seller in Q4 2024 was Renaissance Technologies, an estimated $111K sold.
Based on aggregated 13F filings for Q4 2024.